Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study

Elif Suyani1, Mehmet Akif Ozturk, Serpil Muge Deger

  • 1Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey. elifsuyani@hotmail.com

Clinical Rheumatology
|June 17, 2008
PubMed

Insights

Adult patients with familial Mediterranean fever (FMF) show decreased bone mineral density in the femur. This suggests subclinical inflammation may impact bone health in FMF patients, even when disease-free.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Orthopedics

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease.
  • Osteoporosis (OP) is a significant public health concern characterized by low bone mass and microarchitectural deterioration.
  • The relationship between FMF and bone health, specifically osteoporosis, requires further investigation.

Purpose of the Study:

  • To investigate the association between familial Mediterranean fever (FMF) and osteoporosis (OP) in adult patients.
  • To compare bone mineral density (BMD) in FMF patients and matched healthy controls.

Main Methods:

  • A case-control study involving 35 attack-free FMF patients matched with healthy controls.
  • Bone mineral density (BMD) measured at the spine and femur using dual-energy X-ray absorptiometry (DXA).
  • Exclusion of subjects with conditions known to affect BMD.

Main Results:

  • No significant difference in BMD T-scores at the spine or femur neck between FMF patients and controls.
  • Significantly lower total femur T-scores observed in FMF patients compared to healthy controls (p = 0.021).
  • Adult FMF patients exhibited decreased total femur bone mineral density.

Conclusions:

  • Adult patients with familial Mediterranean fever demonstrate reduced bone mineral density in the total femur.
  • Ongoing subclinical inflammation in FMF may contribute to decreased bone mineral content.
  • Further research is warranted to elucidate the mechanisms linking FMF and bone loss.